Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:10 PM by

London, UK. 14th December 2020: Page & Page and Partners, the global creative communications agency specialising in health, wellness, and lifestyle, is today announcing the appointment of two new full-time staff. The new joiners are: Kirstie Turner – Writer and editor and Georgie Epps – Mid weight creative.

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

IntelyCare reports record growth in 2020 amid surging demand for data science-driven staffing technology in the post-acute market.

Dec 16, 2020, 14:10 PM by

Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, is working with leading scientific experts at Lund University (Sweden), Gothenburg University (Sweden) and in China to develop new diagnostics methods and software solutions to significantly improve disease stratification and treatment selection of patients diagnosed with cancer.

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

iVexSol, a Worcester, MA-based manufacturer of lentiviral vector (LVV), announced a $13.0M Series A funding round. LVV is a critical raw material in the development of important new cell and gene therapies. iVexSol’s technology can reliably produce LVV at significantly greater quantities than traditional processes, enabling a smaller manufacturing footprint, and facilitating the rapid scale-out needed for global demand. The funding will be used to establish a cGMP manufacturing facility in Lexington, MA.

Dec 16, 2020, 14:10 PM by

Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research

Dec 16, 2020, 14:10 PM by

• Start-up to leverage gamification and cognitive rehabilitation targeting cognition, mood and behaviors in patients with mild-to-moderate Alzheimer’s disease • Digital therapeutics solution collects digital biomarkers via computer tablets in the home to assess and monitor cognitive function, thereby delivering personalized cognitive intervention • Can be prescribed as a stand-alone therapeutic or as combination therapy with a drug

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:08 PM by

A new study reveals that VisualDx's artificial intelligence solution identifies skin conditions with 68% accuracy across all skin types.

Dec 16, 2020, 14:07 PM by

The press release announces it has supplied KROHNE OPTIMASS 6400 Coriolis mass flowmeters for measuring purified water used in Covid-19 vaccine production processes. The meters will also be used as a master meter – the standard by which all other production process flow meters will be verified against.

Dec 15, 2020, 10:48 AM by User Not Found

Bio-IT World | Sequencing in the palm of your hand is now a reality. A team of researchers has created iGenomics—the first comprehensive mobile genome analysis application, with capabilities to align reads, call variants, and visualize the results entirely on an iOS device. What started as a high school student’s internship project is now freely available in the App Store.

Dec 14, 2020, 09:09 AM by User Not Found

Bio-IT World | At its re:Invent 2020 event, Amazon AWS announced many new products and services including the new Trainium chip for machine learning.

Dec 11, 2020, 13:46 PM by User Not Found

Bio-IT World I IgA antibodies dominate early neutralizing response, specific proteins in animals increase vulnerability, understanding the roles of antibodies and T cells, and Molnupiravir could block SARS-CoV-2 transmission. Plus: New biomedical data sharing platform, disrupting cholesterol processes may combat COVID-19, and a new project aims to understand formation of coronaviruses.

Dec 10, 2020, 19:06 PM by User Not Found

Bio-IT World | The All of Us Research Program has begun to return genetic results to participants who have donated biosamples for research, NIH announced yesterday. The program prioritizes information return to its research volunteers. Initially, participants can choose to receive information about their genetic ancestry and traits, with health-related results available at a later date.